Telix Pharmaceuticals |
High $11.49 |
Low $11.20 |
Trades 4,718 |
Turnover $7,499,551 |
Volume 664,557 |
| 30 June 2023 at 4:12pm | ||||
|
Market Cap (15-Nov) $4,655,044,608 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (9-Nov) 35,408,995 (10.40%) (16th) |
|
52w High $18.22 |
52w Low $8.26 |
P/E 178.57 |
EPS 0.15 |
Cleansing Notice under S708A(5)(e) Corporations Act
TLX released this announcement to the ASX on 28 February 2022, 9:01. The announcement is not marked as price sensitive, and is 1 page(s) in length and 75.82kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 1.194% short sold according to ASIC data. It was ranked the 173rd most shorted stock on the ASX. It is now ranked as the 16th most shorted stock on the ASX with 10.404% of total shares short sold as of the latest reported data (09 November 2026).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Cleansing Notice under S708A(5)(e) Corporations Act | 28 February 2022, 9:01 |
| Application for quotation of securities - TLX | 28 February 2022, 8:58 |
| 2021 Full Year Results Presentation | 24 February 2022, 8:26 |
| Annual Report for the year ended 31 December 2021 | 24 February 2022, 8:26 |
If you were already registered, log in here.